Form 4: VolitionRx Executive Ann-Louise Batchelor Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRx, reports the withholding of shares to cover tax obligations related to the settlement of restricted stock units.
Summary
- On September 28, 2024, Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRx Ltd, had 5,604 shares of common stock withheld by VolitionRx to satisfy tax obligations.
- The shares were withheld at a price of $0.578 per share.
- Following the transaction, Batchelor directly owns 107,676 shares of VolitionRx common stock.
- Batchelor also indirectly owns 29,406 shares through her spouse.
Sentiment
Score: 5
Explanation: This is a neutral filing related to tax obligations, with no inherent positive or negative implications for the company's overall prospects.
Industry Context
This is a standard Form 4 filing, which is a routine part of corporate governance and transparency, ensuring that insider transactions are disclosed to the public.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it relates to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of the transaction where shares were withheld for tax obligations. |
| 10/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.